Vanta Bioscience Balance Sheet Health
Financial Health criteria checks 0/6
Vanta Bioscience has a total shareholder equity of ₹193.0M and total debt of ₹571.1M, which brings its debt-to-equity ratio to 295.9%. Its total assets and total liabilities are ₹846.0M and ₹653.0M respectively.
Key information
295.9%
Debt to equity ratio
₹571.13m
Debt
Interest coverage ratio | n/a |
Cash | ₹1.37m |
Equity | ₹193.02m |
Total liabilities | ₹653.00m |
Total assets | ₹846.02m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540729's short term assets (₹151.3M) do not cover its short term liabilities (₹184.0M).
Long Term Liabilities: 540729's short term assets (₹151.3M) do not cover its long term liabilities (₹469.0M).
Debt to Equity History and Analysis
Debt Level: 540729's net debt to equity ratio (295.2%) is considered high.
Reducing Debt: 540729's debt to equity ratio has increased from 68.6% to 295.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 540729 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 540729 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.3% each year